Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan
· Delayed Price · Currency is TWD 129.00
0.00 (0.00%)
Apr 29, 2026, 1:30 PM CST
TPEX:6712 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 222.16 | 301.68 | 336.44 | 353.57 | 641.1 | Upgrade
|
| Short-Term Investments | 213.5 | 636.5 | 998.6 | 915.99 | 702.6 | Upgrade
|
| Cash & Short-Term Investments | 435.66 | 938.18 | 1,335 | 1,270 | 1,344 | Upgrade
|
| Cash Growth | -53.56% | -29.73% | 5.16% | -5.52% | 223.80% | Upgrade
|
| Accounts Receivable | 229.47 | 193.99 | 100.63 | 84.94 | 33.66 | Upgrade
|
| Other Receivables | 7.73 | 7.56 | 0.46 | 0.88 | 29.6 | Upgrade
|
| Receivables | 237.19 | 201.54 | 101.09 | 85.82 | 63.27 | Upgrade
|
| Inventory | 75.71 | 80.04 | 69.09 | 88.3 | 56.77 | Upgrade
|
| Prepaid Expenses | 3.3 | 3.44 | 7.92 | 6.29 | 2.11 | Upgrade
|
| Other Current Assets | 0.83 | 0.06 | 7.73 | 5.46 | 0.92 | Upgrade
|
| Total Current Assets | 752.68 | 1,223 | 1,521 | 1,455 | 1,467 | Upgrade
|
| Property, Plant & Equipment | 74.68 | 48.58 | 64.81 | 89.84 | 125.01 | Upgrade
|
| Long-Term Investments | 1,062 | 796.16 | 471.31 | 376.37 | 333.27 | Upgrade
|
| Other Intangible Assets | 13.39 | 10.15 | 10.65 | 11.95 | 11.14 | Upgrade
|
| Long-Term Deferred Tax Assets | 10.98 | 10.73 | 1.71 | 30.32 | 78.2 | Upgrade
|
| Other Long-Term Assets | 90.27 | 47.24 | 6.57 | 9.72 | 8.22 | Upgrade
|
| Total Assets | 2,004 | 2,136 | 2,076 | 1,974 | 2,023 | Upgrade
|
| Accounts Payable | 43.41 | 25.13 | 23.33 | 29.08 | 15 | Upgrade
|
| Accrued Expenses | 1.61 | 2.4 | 1.96 | 3.98 | 10.49 | Upgrade
|
| Current Portion of Leases | 10.38 | 1.71 | 5.4 | 4.5 | 11.87 | Upgrade
|
| Current Income Taxes Payable | 45.89 | 68.07 | 46.76 | 10.47 | 21.04 | Upgrade
|
| Current Unearned Revenue | 290.98 | 194.13 | 121.65 | 89.89 | 12.22 | Upgrade
|
| Other Current Liabilities | 30.28 | 37.66 | 32.55 | 25.82 | 25.9 | Upgrade
|
| Total Current Liabilities | 422.55 | 329.09 | 231.64 | 163.74 | 96.51 | Upgrade
|
| Long-Term Leases | 28.37 | 1.14 | 0.5 | 13.36 | 22.55 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 8.57 | 10.82 | - | 3.59 | 3.82 | Upgrade
|
| Other Long-Term Liabilities | 18.32 | 0.78 | 0.82 | 0.76 | 1.96 | Upgrade
|
| Total Liabilities | 477.8 | 341.82 | 232.96 | 181.45 | 124.83 | Upgrade
|
| Common Stock | 875.97 | 806.73 | 733.39 | 681.4 | 618.18 | Upgrade
|
| Additional Paid-In Capital | 509.31 | 551.72 | 785.91 | 872.22 | 1,211 | Upgrade
|
| Retained Earnings | 218.3 | 434.23 | 323.67 | 238.51 | 68.74 | Upgrade
|
| Comprehensive Income & Other | -77.03 | 1.6 | - | 0.04 | - | Upgrade
|
| Shareholders' Equity | 1,527 | 1,794 | 1,843 | 1,792 | 1,898 | Upgrade
|
| Total Liabilities & Equity | 2,004 | 2,136 | 2,076 | 1,974 | 2,023 | Upgrade
|
| Total Debt | 38.75 | 2.84 | 5.9 | 17.86 | 34.42 | Upgrade
|
| Net Cash (Debt) | 396.91 | 935.33 | 1,329 | 1,252 | 1,309 | Upgrade
|
| Net Cash Growth | -57.56% | -29.63% | 6.19% | -4.40% | 252.17% | Upgrade
|
| Net Cash Per Share | 4.51 | 10.54 | 14.72 | 13.72 | 14.38 | Upgrade
|
| Filing Date Shares Outstanding | 87.6 | 88.74 | 88.74 | 90.67 | 90.48 | Upgrade
|
| Total Common Shares Outstanding | 87.6 | 88.74 | 88.74 | 90.67 | 90.48 | Upgrade
|
| Working Capital | 330.14 | 894.16 | 1,289 | 1,292 | 1,370 | Upgrade
|
| Book Value Per Share | 17.43 | 20.22 | 20.77 | 19.77 | 20.97 | Upgrade
|
| Tangible Book Value | 1,513 | 1,784 | 1,832 | 1,780 | 1,887 | Upgrade
|
| Tangible Book Value Per Share | 17.27 | 20.11 | 20.65 | 19.63 | 20.85 | Upgrade
|
| Machinery | 94.91 | 93.5 | 91.2 | 85.39 | 82.64 | Upgrade
|
| Leasehold Improvements | 63.28 | 63.28 | 65.23 | 65.23 | 63.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.